Illumina Inc (NASDAQ: ILMN) has experienced a rise in its stock price by 2.65 compared to its previous closing price of 130.12. However, the company has seen a gain of 3.93% in its stock price over the last five trading days. Reuters reported 2024-04-09 that Illumina said on Tuesday Chief Financial Officer Joydeep Goswami would leave the gene sequencing company and would be succeeded by former Summit Therapeutics’ executive Ankur Dhingra.
Is It Worth Investing in Illumina Inc (NASDAQ: ILMN) Right Now?
The 36-month beta value for ILMN is at 1.19. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 6 rating it as “overweight,” 6 as “hold,” and 1 as “sell.”
The public float for ILMN is 158.11M, and currently, shorts hold a 3.29% of that float. The average trading volume for ILMN on April 10, 2024 was 1.77M shares.
ILMN’s Market Performance
ILMN stock saw a decrease of 3.93% in the past week, with a monthly decline of -1.37% and a quarterly a decrease of -0.07%. The volatility ratio for the week is 3.54%, and the volatility levels for the last 30 days are 3.68% for Illumina Inc (ILMN). . The simple moving average for the past 20 days is 0.87% for ILMN’s stock, with a -6.71% simple moving average for the past 200 days.
Analysts’ Opinion of ILMN
TD Cowen, on the other hand, stated in their research note that they expect to see ILMN reach a price target of $144. The rating they have provided for ILMN stocks is “Market Perform” according to the report published on January 04th, 2024.
Scotiabank gave a rating of “Sector Outperform” to ILMN, setting the target price at $185 in the report published on December 18th of the previous year.
ILMN Trading at -2.55% from the 50-Day Moving Average
After a stumble in the market that brought ILMN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.64% of loss for the given period.
Volatility was left at 3.68%, however, over the last 30 days, the volatility rate increased by 3.54%, as shares sank -3.95% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.02% lower at present.
During the last 5 trading sessions, ILMN rose by +3.93%, which changed the moving average for the period of 200-days by -33.93% in comparison to the 20-day moving average, which settled at $132.14. In addition, Illumina Inc saw -4.07% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ILMN starting from Thaysen Jacob, who purchase 7,330 shares at the price of $135.29 back on Feb 22 ’24. After this action, Thaysen Jacob now owns 14,861 shares of Illumina Inc, valued at $991,672 using the latest closing price.
Hoyt Aimee L, the SVP, Chief People Officer of Illumina Inc, sale 315 shares at $112.84 during a trade that took place back on Nov 07 ’23, which means that Hoyt Aimee L is holding 8,314 shares at $35,545 based on the most recent closing price.
Stock Fundamentals for ILMN
Current profitability levels for the company are sitting at:
- -0.21 for the present operating margin
- 0.61 for the gross margin
The net margin for Illumina Inc stands at -0.26. The total capital return value is set at -0.11. Equity return is now at value -18.81, with -10.38 for asset returns.
Based on Illumina Inc (ILMN), the company’s capital structure generated 0.22 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at 0.27. The interest coverage ratio of the stock is 160.5.
Currently, EBITDA for the company is 362.0 million with net debt to EBITDA at 1.5. When we switch over and look at the enterprise to sales, we see a ratio of 4.98. The receivables turnover for the company is 5.99for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.66.
Conclusion
In conclusion, Illumina Inc (ILMN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
